β-Catenin is required for Ron receptor-induced mammary tumorigenesis
about
Pathogenesis of RON receptor tyrosine kinase in cancer cells: activation mechanism, functional crosstalk, and signaling addictionRon receptor tyrosine kinase signaling as a therapeutic targetRon receptor signaling is protective against DSS-induced colitis in mice.Suppression Of β-catenin Nuclear Translocation By CGP57380 Decelerates Poor Progression And Potentiates Radiation-Induced Apoptosis in Nasopharyngeal Carcinoma.The DEK oncogene promotes cellular proliferation through paracrine Wnt signaling in Ron receptor-positive breast cancersIntron retention in the alternatively spliced region of RON results from weak 3' splice site recognition.The Ron receptor promotes prostate tumor growth in the TRAMP mouse model.Ron receptor overexpression in the murine prostate induces prostate intraepithelial neoplasia.Can we safely target the WNT pathway?Estrogen receptor alpha deletion enhances the metastatic phenotype of Ron overexpressing mammary tumors in mice.Conditional deletion of β-catenin in mammary epithelial cells of Ron receptor, Mst1r, overexpressing mice alters mammary tumorigenesis.Vitamin D3-dependent VDR signaling delays ron-mediated breast tumorigenesis through suppression of β-catenin activity.CD151 represses mammary gland development by maintaining the niches of progenitor cells.RanBPM expression regulates transcriptional pathways involved in development and tumorigenesis.HGFL supports mammary tumorigenesis by enhancing tumor cell intrinsic survival and influencing macrophage and T-cell responses.Wnt signaling in mammary glands: plastic cell fates and combinatorial signaling.The RON receptor tyrosine kinase is a potential therapeutic target in Burkitt lymphoma.Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression.FOXC1 promotes melanoma by activating MST1R/PI3K/AKT.Safely targeting cancer stem cells via selective catenin coactivator antagonism.Kat3 coactivators in somatic stem cells and cancer stem cells: biological roles, evolution, and pharmacologic manipulation.CBP/Catenin antagonists: Targeting LSCs' Achilles heel.HGFL-mediated RON signaling supports breast cancer stem cell phenotypes via activation of non-canonical β-catenin signaling.Sequential delivery of erlotinib and doxorubicin for enhanced triple negative Breast cancer treatment using polymeric nanoparticle.Delayed Sequential Co-Delivery of Gefitinib and Doxorubicin for Targeted Combination Chemotherapy.Myoepithelial and luminal breast cancer cells exhibit different responses to all-trans retinoic acid.Tumor Cell Autonomous RON Receptor Expression Promotes Prostate Cancer Growth Under Conditions of Androgen Deprivation
P2860
Q26864275-A8E578C9-8DBF-4744-B573-BD60AC655D57Q27003295-226CC59A-B75B-46A2-B8AF-417C1DBCF86FQ33764576-409AC782-AAFA-4533-A147-2BC3C2D38E85Q33836444-F21D357B-8535-44B6-AC36-2249A06B2DC2Q34765982-4EA24FBC-0C68-4F8B-BBD7-100C806BE5EEQ35025393-1D118160-1DC5-4138-8F3B-B171B586E630Q35190869-9922D91B-948C-4EA8-BC21-5192AC42EB24Q35577352-A3830333-DFF9-4CA0-88D2-236E1EFEC2F2Q35591995-374522BC-58F7-4E13-83C4-A809A2B87F80Q35777328-1394D472-5F3C-42F9-831F-A23E514DBC83Q35986081-04026266-5677-4868-982A-23227A685D80Q36140785-879253D6-F7E4-4E2E-AF98-F3915823B304Q36188917-36FD501D-3C3B-4359-A90E-7F686BE98B5CQ36206487-915018C2-0E5E-4D6C-8EC0-285D7DC3B8CDQ36232073-DA0DEC94-F043-4BEF-84E8-5322DBAFA0B6Q36329477-B2073E77-83C0-4D26-9B20-8895271E3DFDQ36887780-81E3F70C-49AA-44C4-B339-7F197A5A9799Q37109753-DCD83425-E80A-4B4A-ABD1-34DCBFD8C3B6Q37708952-4CD50F54-20A6-475D-98C6-43126DBBDACCQ38224211-3CCD134D-0516-4099-AF76-B08FA3295AA8Q38786359-2056F887-A854-4069-93C3-DE6D52194A2EQ39289235-2B19045A-5741-4390-9948-AB151DC9FA20Q41708922-C4E35B58-293E-4A16-B9DB-8912AD67DB85Q47138564-BCFB84DF-0153-423E-AC55-52BECCF264EEQ47403872-C1AE00DF-ED16-4223-B0BE-EF48DDFF463DQ52938678-6001CC3A-63AE-4B72-B3F4-61D68548DBFCQ58777826-7DED27AC-FFBF-47FF-ABBD-D609FAF751E0
P2860
β-Catenin is required for Ron receptor-induced mammary tumorigenesis
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
β-Catenin is required for Ron receptor-induced mammary tumorigenesis
@ast
β-Catenin is required for Ron receptor-induced mammary tumorigenesis
@en
type
label
β-Catenin is required for Ron receptor-induced mammary tumorigenesis
@ast
β-Catenin is required for Ron receptor-induced mammary tumorigenesis
@en
prefLabel
β-Catenin is required for Ron receptor-induced mammary tumorigenesis
@ast
β-Catenin is required for Ron receptor-induced mammary tumorigenesis
@en
P2093
P2860
P356
P1433
P1476
β-Catenin is required for Ron receptor-induced mammary tumorigenesis
@en
P2093
G M Zinser
J Vasiliauskas
P2860
P2888
P304
P356
10.1038/ONC.2011.86
P407
P577
2011-03-21T00:00:00Z